Climate has a major impact on fungal spore patterns. The types of fungi, timing of spore release, and health risks vary greatly between temperate, tropical, arid, and cold climates.
🌦️ Temperate Climates (e.g. UK, Northern Europe, Pacific Northwest USA)
-
Seasonal peaks: late summer to early autumn
-
Cladosporium, Alternaria, Aspergillus, Penicillium dominate
-
Triggers: humidity, rain, decaying vegetation, compost
-
Evening/night peaks for many spore types
🧠 Health risk: ABPA, asthma, SAFS, especially after garden work or composting
🌴 Tropical and Subtropical Climates (e.g. SE Asia, Central America, parts of Africa)
-
High year-round spore loads
-
Fungi: Aspergillus, Rhizopus, Mucor, Curvularia, Basidiomycetes, tropical molds
-
Daily rain cycles promote spore germination and release
-
Basidiospores and hyaline molds surge during evening and after rainfall
🧠 Higher incidence of fungal sinusitis, allergic fungal rhinosinusitis, and invasive infections in immunocompromised patients
🏜️ Arid and Semi-Arid Climates (e.g. Southwest USA, parts of the Middle East, Northern Africa)
-
Lower general spore burden, but dust storms can release huge amounts
-
Fungi: Coccidioides spp. (Valley fever), Aspergillus, dryland molds
-
Dry conditions favour small, dry spores that aerosolise easily
-
Wind and soil disturbance (construction, farming) are major triggers
🧠 Coccidioidomycosis, aspergillosis, dust-related asthma
❄️ Cold or Alpine Climates (e.g. Scandinavia, Alps, Canadian north)
-
Lower fungal biodiversity
-
Short seasonal spore peaks (spring–summer)
-
Indoor exposure more relevant: Penicillium, Cladosporium, Aspergillus
-
Mold growth occurs in poorly ventilated buildings (e.g. after snow melts)
🧠 Winter indoor mould exposure can worsen asthma, ABPA, SAFS
📌 Key Takeaway:
Different climates = different fungal threats.
The more humid, warm, or plant-rich the environment, the more active and diverse the fungal spore release — but indoor mould exposure is relevant in every climate.
Share this post
Latest News posts
Physiotherapy and Aspergillosis: Why It Matters
December 2, 2025
🌐 Promoting the NHS National Aspergillosis Centre (NAC)
November 27, 2025
News archive
- ABPA
- Air Quality
- Airway Clearance, Diagnosis & Physiotherapy
- Antifungals
- Aspergilloma
- Aspergillus Bronchitis
- Biologics
- CPA
- Carers & Family
- Complementary & Supplements
- Complications
- Conditions
- Diagnostics
- Environment
- Events & Recordings
- GP Guidance
- General interest
- Housing & Damp
- Immune System
- Lifestyle & Coping
- Living with Aspergillosis
- Mental Health
- Mental Health
- Monitoring
- Monitoring & Safety
- NAC & Research
- NAC Announcements
- Professional Guidance
- Recordings
- Research
- Research Summaries
- Research Summaries
- SAFS / Severe Asthma
- Side Effects
- Steroids
- Symptoms
- Travel & Insurance
- Treatment
- Vaccines
- Weekly Updates
